Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease· 2017 · 302 citations
2. One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study· 2017 · 177 citations
3. Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn’s Disease and Ulcerative Colitis· 2017 · 74 citations
4. Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time· 2017 · 34 citations
5. Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease· 2018 · 122 citations